-
Founded in:
2003-05-26 -
Country:
China -
Address:
Building 028A, Hebin North Industrial Zone, Dananshan Street, Puning City -
Tax NO.:
91445281751053306H -
Registered Funds:
5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Neomycin sulfate |
Aminoglycoside antibiotics have significant antibacterial effects on Staphylococcus, Corynebacterium, Escherichia coli, Klebsiella, Proteus and Enterobacter, etc. Topical eye drops are rarely absorbed into the eye tissue and blood.
More
Aminoglycoside antibiotics have significant antibacterial effects on Staphylococcus, Corynebacterium, Escherichia coli, Klebsiella, Proteus and Enterobacter, etc. Topical eye drops are rarely absorbed into the eye tissue and blood. |
3.0mg | 1405-10-3 | 10 |
| Dexamethasone sodium phosphate |
Glucocorticoids are drugs with anti-inflammatory, anti-allergic and immunosuppressive effects.
More
Glucocorticoids are drugs with anti-inflammatory, anti-allergic and immunosuppressive effects. |
1.0mg | 55203-24-2 | 24 |
| Sodium hyaluronate |
Neomycin sulfate is an aminoglycoside antibiotic that has significant antibacterial effects on Staphylococcus, Corynebacterium, Escherichia coli, Klebsiella, Proteus and Enterobacter. Topical eye drops are rarely absorbed into the eye tissue and blood. Dexamethasone sodium phosphate is a glucocorticoid drug with anti-inflammatory, anti-allergic and immunosuppressive effects.
More
Neomycin sulfate is an aminoglycoside antibiotic that has significant antibacterial effects on Staphylococcus, Corynebacterium, Escherichia coli, Klebsiella, Proteus and Enterobacter. Topical eye drops are rarely absorbed into the eye tissue and blood. Dexamethasone sodium phosphate is a glucocorticoid drug with anti-inflammatory, anti-allergic and immunosuppressive effects. |
2.0mg | 9067-32-7 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ribavirin |
Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.
More
Antiviral drug. It has the effect of inhibiting the growth of many viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro, and its mechanism is not fully understood. This product does not change the adsorption, invasion and uncoating of viruses, nor does it induce the production of interferon. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus. |
36791-04-5 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Idoxuridine |
This product is a pyrimidine antiviral drug that can competitively inhibit phosphorylase, especially DNA polymerase, with thymidine nucleoside, thereby inhibiting the synthesis of thymidine nucleoside in viral DNA, or replacing thymidine nucleoside to penetrate into viral DNA, producing defective DNA, making it lose its infectivity or unable to recombine, so that the virus stops reproducing or loses its activity and is inhibited.
More
This product is a pyrimidine antiviral drug that can competitively inhibit phosphorylase, especially DNA polymerase, with thymidine nucleoside, thereby inhibiting the synthesis of thymidine nucleoside in viral DNA, or replacing thymidine nucleoside to penetrate into viral DNA, producing defective DNA, making it lose its infectivity or unable to recombine, so that the virus stops reproducing or loses its activity and is inhibited. |
54-42-2 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Motherwort Herb P.E. |
Not yet clear
More
Not yet clear |
0 | ||
| Angelicae Sinensis Radix |
Not yet clear
More
Not yet clear |
0 | ||
| Riligustilide |
Not yet clear
More
Not yet clear |
89354-45-0 | 0 | |
| Aucklandiae Radix |
Not yet clear
More
Not yet clear |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Undecenoic acid |
This product is an antifungal drug, and its mechanism of action is to inhibit the growth and reproduction of fungi.
More
This product is an antifungal drug, and its mechanism of action is to inhibit the growth and reproduction of fungi. |
112-38-9 | 1 |